Á lódáil...
Targeting HER3 using mono- and bispecific antibodies or alternative scaffolds
The human epidermal growth factor receptor 3 (HER3) has in recent years been recognized as a key node in the complex signaling network of many different cancers. It is implicated in de novo and acquired resistance against therapies targeting other growth factor receptors, e.g., EGFR, HER2, and it is...
Na minha lista:
| Foilsithe in: | MAbs |
|---|---|
| Main Authors: | , , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
Taylor & Francis
2016
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5058629/ https://ncbi.nlm.nih.gov/pubmed/27532938 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19420862.2016.1212147 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|